"10.1371_journal.pone.0006138","plos one","2009-07-09T00:00:00Z","Ilja M Nolte; Chris Wallace; Stephen J Newhouse; Daryl Waggott; Jingyuan Fu; Nicole Soranzo; Rhian Gwilliam; Panos Deloukas; Irina Savelieva; Dongling Zheng; Chrysoula Dalageorgou; Martin Farrall; Nilesh J Samani; John Connell; Morris Brown; Anna Dominiczak; Mark Lathrop; Eleftheria Zeggini; Louise V Wain; for the The Wellcome Trust Case Control Consortium; The DCCT/EDIC Research Group; Christopher Newton-Cheh; Mark Eijgelsheim; Kenneth Rice; Paul I W de Bakker; for the QTGEN consortium; Arne Pfeufer; Serena Sanna; Dan E Arking; for the QTSCD consortium; Folkert W Asselbergs; Tim D Spector; Nicholas D Carter; Steve Jeffery; Martin Tobin; Mark Caulfield; Harold Snieder; Andrew D Paterson; Patricia B Munroe; Yalda Jamshidi","Unit of Genetic Epidemiology and Bioinformatics, Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; Clinical Pharmacology and Barts and the London Genome Centre, William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom; Department of Twin Research and Genetic Epidemiology Unit, St Thomas Campus, Kings College London, St Thomas Hospital, London, United Kingdom; Cardiological Sciences, Division of Cardiac and Vascular Sciences, St Georges University of London, London, United Kingdom; Division of Clinical Developmental Sciences, St Georges University of London, London, United Kingdom; Department of Cardiovascular Medicine, University of Oxford, Wellcome Trust Centre for Human Genetics, Oxford, United Kingdom; Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester, United Kingdom; BHF Glasgow Cardiovascular Research Centre, Division of Cardiovascular and Medical Sciences, University of Glasgow, Western Infirmary, Glasgow, United Kindom; Clinical Pharmacology and the Cambridge Institute of Medical Research, University of Cambridge, Addenbrookes Hospital, Cambridge, United Kingdom; Centre National de Genotypage, Evry, France; The Wellcome Trust Centre for Human Genetics, Oxford, United Kingdom; Departments of Health Sciences & Genetics, University of Leicester, Leicester, United Kingdom; Center for Human Genetic Research, Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America; NHLBIs Framingham Heart Study, Framingham, Massachusetts, United States of America; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America; Division of Genetics, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School-Partners HealthCare Center for Genetics and Genomics, Boston, Massachusetts, United States of America; Institute of Human Genetics, Technical University Munich, Munich, Germany; Institute of Human Genetics, Helmholtz Center Munich, Munich, Germany; Istituto di Neurogenetica e Neurofarmacologia, CNR, Monserrato, Cagliari, Italy; McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; Genetics and Genomic Biology, The Hospital for Sick Children, Toronto, Ontario, Canada","Conceived and designed the experiments: CW MJC HS AP PM YJ. Analyzed the data: IMN CW SJN DW JF NS EZ LVW MDT HS AP PM YJ. Wrote the paper: IMN MDT MJC HS AP PM YJ. GWAS genotyping team: RG PD. Data collection and phenotyping: IS DZ CD MF NJS JC MB AD GML CNC FWA TDS NC SJ. In silico data: ME KR PdB AP SS DEA.","Aravinda Chakravarti is a paid member of the Scientific Advisory Board of Affymetrix, a role that is managed by the Committee on Conflict of Interest of the Johns Hopkins University School of Medicine.","2009","07","Ilja M Nolte","IMN",40,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
